New gel could make eye injections Pain-Free
NCT ID NCT07456826
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new numbing gel (chloroprocaine HCl 3%) to standard eye drops plus a shot for pain relief during eye injections. About 236 adults with conditions like diabetic macular edema or age-related macular degeneration will take part. The goal is to see if the gel works as well as the usual method to keep patients comfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tyler Retina Research Institute
Tyler, Texas, 75703, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Longer-Lasting eye injection could cut treatment visits for macular disease
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can At-Home eye scans personalize wet AMD treatment?
- Can a new eye injection save vision in wet AMD?
- Can a new eye injection beat the current standard for diabetic vision loss?
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out